UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Are Results From Intermediate-Risk Prostate Cancer Patients Treated Within Clinical Trials Applicable to Real Life?

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E243-E243

2015

Volltextzugriff (PDF)

N107C/CEC.3: A Phase III Trial of Post-Operative Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease

International journal of radiation oncology, biology, physics, 2016-12, Vol.96 (5), p.937-937

2016

Volltextzugriff (PDF)

Report of NRG Oncology/RTOG 9601, A Phase 3 Trial in Prostate Cancer: Anti-androgen Therapy (AAT) With Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) With pT2-3pN0 Disease and an Elevated PSA

International journal of radiation oncology, biology, physics, 2016, Vol.94 (1), p.3-3

2016

Volltextzugriff (PDF)

Patient-Reported Outcomes in NRG Oncology/RTOG 0938, a Randomized Phase 2 Study Evaluating 2 Ultrahypofractionated Regimens (UHRs) for Prostate Cancer

International journal of radiation oncology, biology, physics, 2016, Vol.94 (1), p.2-2

2016

Volltextzugriff (PDF)

Bowel and Bladder Function of Men on a Phase 3 Randomized Study of High Versus Standard Dose of 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.S199-S200

2015

Volltextzugriff (PDF)

Acute and Late Urinary Toxicity After Radiation Therapy in Men With and Without an Intact Prostate Gland: A Secondary Analysis of RTOG 9408 and 9601 Suggesting This Toxicity is Not Due to Bladder Injury

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S14-S14

2012

Volltextzugriff (PDF)

PO-0678 HYPOFRACTIONATION WITH ANDROGEN DEPRIVATION THERAPY IN PROSTATE CANCER: RESULTS AT 8 YEARS

Radiotherapy and oncology, 2012-05, Vol.103, p.S264-S264

2012

Volltextzugriff (PDF)

1044 poster THE IMPACT OF ANTI-COAGULANTS AND STATINS ON PROSTATE CANCER

Radiotherapy and oncology, 2011, Vol.99, p.S389-S389

2011

Volltextzugriff (PDF)

Symptomatic Posttreatment Edema after Stereotactic Radiotherapy for Intracranial Meningiomas: Patterns and Predictive Factors

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e85-e85

2023

Volltextzugriff (PDF)

Active Surveillance before Radiotherapy — Outcome and Predictive Factors for Multiple Biopsies before Treatment

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.e890-e890

2020

Volltextzugriff (PDF)

Quality of Life and Weight Variation during Androgen Deprivation Therapy in Patients with High-Risk Prostate Cancer: Long-Term Data from a Phase III Trial

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.e566-e567

2024

Volltextzugriff (PDF)

536 oral RTOG 9601: SALVAGE RT & ANTI-ANDROGEN THERAPY IN PROSTATE CANCER PATIENTS WITH ELEVATED PSA AFTER SURGERY

Radiotherapy and oncology, 2011, Vol.99, p.S219-S219

2011

Volltextzugriff (PDF)

Single-Arm, Open-Label Phase II Study of Intravenously Administered Tirapazamine and Radiation Therapy for Glioblastoma Multiforme

Journal of clinical oncology, 2000-03, Vol.18 (6), p.1254-1259

2000

Volltextzugriff (PDF)

Patient Reported Outcomes in High-Risk Prostate Cancer Patients with or without Testosterone Recovery after Androgen Deprivation Therapy

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.S95-S96

2023

Volltextzugriff (PDF)

139 poster: Brachytherapy in the Province of Quebec: A Pattern of Use Study

Radiotherapy and oncology, 2009-05, Vol.91, p.S50-S51

2009

Volltextzugriff (PDF)

Demographic Differences Between Consenting versus Non-Consenting Participants for Biospecimen Collection on NRG Prostate Cancer Trials

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.e543-e544

2024

Volltextzugriff (PDF)

Biochemical Recurrence is Not a Surrogate for Overall Survival in Localized Prostate Cancer: Data from 2 Phase III Trials

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.e566-e566

2024

Volltextzugriff (PDF)

Incidence of cardiovascular death in localized prostate cancer and its relationship to androgen blockade: Long-term data from two phase III trials

European urology, 2024-03, Vol.85, p.S1513

2024

Volltextzugriff (PDF)

A0601 - Incidence of cardiovascular death in localized prostate cancer and its relationship to androgen blockade: Long-term data from two phase III trials

European urology, 2024-03, Vol.85, p.S1513-S1513

2024

Volltextzugriff (PDF)

Long-Term Outcomes of NRG/RTOG 0126, a Randomized Trial of High Dose (79.2 Gy) vs. Standard Dose (70.2 Gy) Radiation Therapy (RT) for Men with Localized Prostate Cancer

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.S4-S5

2023

Volltextzugriff (PDF)

Patterns of Failure after Stereotactic Radiosurgery vs. Whole Brain Radiotherapy for Resected Brain Metastases: Central Imaging Review of the N107C/CEC.3 (Alliance) Phase III Clinical Trial

International journal of radiation oncology, biology, physics, 2022-12, Vol.114 (5), p.1063-1064

2022

Volltextzugriff (PDF)

Combined Risk Factors and Outcomes in High-Risk Prostate Cancer: Secondary Analysis of a Phase III Trial

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.e233-e234

2022

Volltextzugriff (PDF)

Cardiovascular Causes of Death in Patients Treated for Localized Prostate Cancer

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.e234

2022

Volltextzugriff (PDF)

Outcomes Comparison Using PSA Cut-Off Values Of 0.1 Or 0.2 Ng/Ml At 6 Months In Localized High-Risk Prostate Cancer Treated With Androgen Deprivation Therapy And Radiotherapy: Prospective Data From A Phase III Trial

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.e855-e855

2020

Volltextzugriff (PDF)

Body Composition and Risk of All-Cause Mortality in Men Treated With Radiation Therapy for Prostate Cancer: A Pooled Analysis of NRG/RTOG 9406 and NRG/RTOG 0126

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.e285-e286

2021

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCurrent Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(59)

Sprache

Englisch
(58)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Hematology, Oncology And Palliative Medicine
(10)
Life Sciences & Biomedicine
(7)
Science & Technology
(7)
Biological And Medical Sciences
(6)
Medical Sciences
(6)
Radiology
(6)
Clinical Neurology
(5)
Humans
(5)
Middle Aged
(5)
Neurosciences & Neurology
(5)
Aged
(4)
Female
(4)
Male
(4)
Adult
(3)
Combined Modality Therapy
(3)
Oncology
(3)
Prognosis
(3)
Brain Neoplasms - Therapy
(2)
Glioblastoma - Radiotherapy
(2)
Original Articles
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Are Results From Intermediate-Risk Prostate Cancer Patients Treated Within Clinical Trials Applicable to Real Life?

N107C/CEC.3: A Phase III Trial of Post-Operative Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease

Report of NRG Oncology/RTOG 9601, A Phase 3 Trial in Prostate Cancer: Anti-androgen Therapy (AAT) With Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) With pT2-3pN0 Disease and an Elevated PSA

Patient-Reported Outcomes in NRG Oncology/RTOG 0938, a Randomized Phase 2 Study Evaluating 2 Ultrahypofractionated Regimens (UHRs) for Prostate Cancer

Bowel and Bladder Function of Men on a Phase 3 Randomized Study of High Versus Standard Dose of 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer

Acute and Late Urinary Toxicity After Radiation Therapy in Men With and Without an Intact Prostate Gland: A Secondary Analysis of RTOG 9408 and 9601 Suggesting This Toxicity is Not Due to Bladder Injury

PO-0678 HYPOFRACTIONATION WITH ANDROGEN DEPRIVATION THERAPY IN PROSTATE CANCER: RESULTS AT 8 YEARS

1044 poster THE IMPACT OF ANTI-COAGULANTS AND STATINS ON PROSTATE CANCER

Symptomatic Posttreatment Edema after Stereotactic Radiotherapy for Intracranial Meningiomas: Patterns and Predictive Factors

Active Surveillance before Radiotherapy — Outcome and Predictive Factors for Multiple Biopsies before Treatment

Quality of Life and Weight Variation during Androgen Deprivation Therapy in Patients with High-Risk Prostate Cancer: Long-Term Data from a Phase III Trial

536 oral RTOG 9601: SALVAGE RT & ANTI-ANDROGEN THERAPY IN PROSTATE CANCER PATIENTS WITH ELEVATED PSA AFTER SURGERY

Single-Arm, Open-Label Phase II Study of Intravenously Administered Tirapazamine and Radiation Therapy for Glioblastoma Multiforme

Patient Reported Outcomes in High-Risk Prostate Cancer Patients with or without Testosterone Recovery after Androgen Deprivation Therapy

139 poster: Brachytherapy in the Province of Quebec: A Pattern of Use Study

Demographic Differences Between Consenting versus Non-Consenting Participants for Biospecimen Collection on NRG Prostate Cancer Trials

Biochemical Recurrence is Not a Surrogate for Overall Survival in Localized Prostate Cancer: Data from 2 Phase III Trials

Incidence of cardiovascular death in localized prostate cancer and its relationship to androgen blockade: Long-term data from two phase III trials

A0601 - Incidence of cardiovascular death in localized prostate cancer and its relationship to androgen blockade: Long-term data from two phase III trials

Long-Term Outcomes of NRG/RTOG 0126, a Randomized Trial of High Dose (79.2 Gy) vs. Standard Dose (70.2 Gy) Radiation Therapy (RT) for Men with Localized Prostate Cancer

Patterns of Failure after Stereotactic Radiosurgery vs. Whole Brain Radiotherapy for Resected Brain Metastases: Central Imaging Review of the N107C/CEC.3 (Alliance) Phase III Clinical Trial

Combined Risk Factors and Outcomes in High-Risk Prostate Cancer: Secondary Analysis of a Phase III Trial

Cardiovascular Causes of Death in Patients Treated for Localized Prostate Cancer

Outcomes Comparison Using PSA Cut-Off Values Of 0.1 Or 0.2 Ng/Ml At 6 Months In Localized High-Risk Prostate Cancer Treated With Androgen Deprivation Therapy And Radiotherapy: Prospective Data From A Phase III Trial

Body Composition and Risk of All-Cause Mortality in Men Treated With Radiation Therapy for Prostate Cancer: A Pooled Analysis of NRG/RTOG 9406 and NRG/RTOG 0126

Aktive Filter

Suchergebnisse filtern